Association of HLA class I and II genes with Middle East respiratory syndrome coronavirus infection in Koreans

INTRODUCTION: Middle East Respiratory Syndrome (MERS) caused by MERS‐coronavirus (CoV) is a lower respiratory tract disease characterized by a high mortality rate. MERS‐CoV spread from Saudi Arabia to other countries, including South Korea. Dysfunction of the human leukocyte antigen (HLA) system has...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, In‐Cheol, Choi, Eun‐Jeong, Shin, Dong‐Hwan, Kim, Hyoung‐Jae, Choi, Haeyoun, Shin, Hyoung‐Shik, Lim, Dong‐Gyun, Kim, Tai‐Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669699/
https://www.ncbi.nlm.nih.gov/pubmed/34637605
http://dx.doi.org/10.1002/iid3.541
Descripción
Sumario:INTRODUCTION: Middle East Respiratory Syndrome (MERS) caused by MERS‐coronavirus (CoV) is a lower respiratory tract disease characterized by a high mortality rate. MERS‐CoV spread from Saudi Arabia to other countries, including South Korea. Dysfunction of the human leukocyte antigen (HLA) system has many effects due to genetic complexity and its role in the adaptive immune response. We investigated the association of HLA class I and II alleles with MERS‐CoV in 32 patients with MERS. METHODS: HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQB1, and ‐DPB1 were genotyped by polymerase chain reaction sequence‐based typing. RESULTS: HLA‐DQB1*03:02 are significantly associated with moderate/mild cases of MERS‐CoV. Other alleles are no statistical significance. CONCLUSIONS: Treatment strategies based on current research on the HLA gene and MERS‐CoV will provide potential therapeutic targets.

Ejemplares similares